Recombinant Human IGFBP7

• Description:

  IBP-7 is a secreted glycoprotein which mediates skeletal myogenesis by binding to IGF and inhibiting its ability to induce skeletal myoblast differentiation while maintaining a constant growth of myoblasts. It has been shown that IBP-7 suppresses growth of cancer cell lines through an IGF independent pathway.

• Gene Name:

  IGFBP7

• Gene Aliases:

  IBP-7, IGF-binding protein 7, IGFBP-7, IGFBP-rP1, MAC25 protein, PGI2-stimulating factor, Prostacyclin-stimulating factor, Tumor-derived adhesion factor, TAF, Angiomodulin, AGM
  Recombinant Human Insulin-Like Growth Factor Binding Protein 7 (IGFBP7)

• Gene ID:

  3490

• Accession Number:

  Q16270

• Organism:

  Human

• Source:

  E. coli

• Concentration:

  <1.0 EU/μg of recombinant protein as determined by the LAL method.

• Purity:

  >95% as determined by SDS-PAGE

• Solubility:

  Reconstitute at 100 μg/mL in sterile PBS

• Function:

  Measured by its ability to bind CCL21 in a functional ELISA

• Molecular Weight:

  26.7

• Shipping Conditions:

  Ambient Temperature

• Storage Conditions:

  The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.

• Appearance:

  Lyophilized Powder

• Formulation:

  Lyophilized from a 0.2 μm filtered solution in PBS

• CAS Number:

  9000-83-3